Citation Impact
Citing Papers
Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes
2017
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
2016
Impact of pre‐analytical parameters on the measurement of circulating microparticles: towards standardization of protocol
2011
Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks
2008
Effect of Aspirin Dose on Mortality and Cardiovascular Events in People with Diabetes: A Meta-Analysis
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Measurement of circulating cell-derived microparticles by flow cytometry: Sources of variability within the assay
2011
Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials
2005
Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A
2009
Combination Antiplatelet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble?
2009
Antiplatelet Drugs
2011
Host genetic determinants of Neisseria meningitidis infections
2003
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis
2011
Cardiovascular Risk Factors and Venous Thromboembolism Incidence
2002
Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis
2016
The genetics of venous and arterial thromboembolism
2001
Assessment of Bleeding Events in Clinical Trials—Proposal of a New Classification
2006
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Pre-analytical and analytical issues in the analysis of blood microparticles
2010
Obesity and Cardiovascular Disease
2009 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Preventable stroke and stroke prevention
2005
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside
2003
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism
2003
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
2016 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions
2003
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis
2013
The Epidemiology of Venous Thromboembolism
2003 Standout
COVID-19 and its implications for thrombosis and anticoagulation
2020 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research
2013 Standout
Detection of circulating microparticles by flow cytometry: influence of centrifugation, filtration of buffer, and freezing
2010
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Guidelines for the management of hemophilia
2012 Standout
Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms
2019
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
2007
Works of Roswith Eisert being referenced
Risk of bleeding complications with antiplatelet agents: Meta‐analysis of 338,191 patients enrolled in 50 randomized controlled trials
2003
Isotype controls in phenotyping and quantification of microparticles: A major source of error and how to evade it
2008
Recovery and composition of microparticles after snap-freezing depends on thawing temperature
2008
Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A
2006
The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism
2003
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism
2000